Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Root Insurance posted its first underwriting profit in 2025, delivering $40.3 million in net income on $1.5 billion i...
Citi lifts Celanese's price target to 81 amid rising Iran risk and potential Strait of Hormuz disruption, pointing to...
GE Vernova sparked intraday excitement as investors reacted to new outlooks on its energy portfolio. This piece break...
When markets punish uncertainty, contrarian investors can find hidden upside. This article highlights three strugglin...
When a major chip stock slips, it sparks questions about why the move happened and what it means for your plan. This ...
A British Columbia senior fell for a Facebook romance scam that drained her savings and left her with overwhelming de...
Anthropic faces a high-stakes regulatory battle in Washington that could redefine how AI startups grow and attract mo...
Job seekers face mounting anxiety as hiring slows despite a tight labor market, leaving many worried about fit, pay, ...
HomeXpress Mortgage Corp. is now live on ARIVE, enabling approved brokers to access non-QM and investor loan products...
From dining room to boardroom, shark tank’s daymond john built a $350 million empire by rejecting shortcuts and inves...
Big-cap U.S. stocks are trading at more attractive levels after a year of resilience and rising macro uncertainty. An...